Last reviewed · How we verify

NCT03717493: ER-BED

Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder

Completed Phase 2, PHASE3 Last updated 28 August 2020
What this trial tests

Phase 2, PHASE3 trial testing Affect Regulation Training in Binge-Eating Disorder in 99 participants. Completed in 1 November 2017.

Timeline
17 December 2012
Primary endpoint
1 May 2017
1 November 2017

Quick facts

Lead sponsorFriedrich-Alexander-Universität Erlangen-Nürnberg
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingsingle
Primary purposetreatment
Enrollment99
Start date17 December 2012
Primary completion1 May 2017
Estimated completion1 November 2017

Drugs / interventions tested

Conditions studied

Sponsor

Friedrich-Alexander-Universität Erlangen-Nürnberg — full company profile →

Who can join

Adults 18 to 69, any sex, with Binge-Eating Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The effectiveness of a systematic affect regulation training (ART; Berking, 2010) is evaluated with regard to reducing symptoms of binge eating disoder in a randomized controlled trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Binge-Eating Disorder

Currently open trials in the same condition.

Other Friedrich-Alexander-Universität Erlangen-Nürnberg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03717493.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing